Corbus Pharmaceuticals Holdings, Inc. (CRBP)
8.97
-0.08
(-0.88%)
USD |
NASDAQ |
Jul 31, 16:00
8.98
+0.01
(+0.11%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Market Cap : 159.12M for July 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 31, 2026 | 159.12M |
| July 30, 2026 | 160.54M |
| July 29, 2026 | 158.23M |
| July 28, 2026 | 161.16M |
| July 27, 2026 | 161.07M |
| July 24, 2026 | 162.67M |
| July 23, 2026 | 165.33M |
| July 22, 2026 | 156.81M |
| July 21, 2026 | 159.30M |
| July 20, 2026 | 157.70M |
| July 17, 2026 | 159.83M |
| July 16, 2026 | 156.10M |
| July 15, 2026 | 159.83M |
| July 14, 2026 | 160.18M |
| July 13, 2026 | 160.36M |
| July 10, 2026 | 171.71M |
| July 09, 2026 | 171.36M |
| July 08, 2026 | 169.41M |
| July 07, 2026 | 166.39M |
| July 06, 2026 | 159.65M |
| July 02, 2026 | 164.08M |
| July 01, 2026 | 160.89M |
| June 30, 2026 | 166.39M |
| June 29, 2026 | 159.30M |
| June 26, 2026 | 155.04M |
| Date | Value |
|---|---|
| June 25, 2026 | 146.35M |
| June 24, 2026 | 145.02M |
| June 23, 2026 | 150.07M |
| June 22, 2026 | 147.41M |
| June 18, 2026 | 146.52M |
| June 17, 2026 | 142.80M |
| June 16, 2026 | 139.78M |
| June 15, 2026 | 147.59M |
| June 12, 2026 | 145.28M |
| June 11, 2026 | 138.01M |
| June 10, 2026 | 136.59M |
| June 09, 2026 | 136.59M |
| June 08, 2026 | 134.11M |
| June 05, 2026 | 134.11M |
| June 04, 2026 | 142.09M |
| June 03, 2026 | 130.91M |
| June 02, 2026 | 133.75M |
| June 01, 2026 | 137.48M |
| May 29, 2026 | 140.31M |
| May 28, 2026 | 135.53M |
| May 27, 2026 | 144.89M |
| May 26, 2026 | 146.55M |
| May 22, 2026 | 210.29M |
| May 21, 2026 | 213.26M |
| May 20, 2026 | 180.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.426B |
| Alnylam Pharmaceuticals, Inc. | 27.49B |
| Anika Therapeutics, Inc. | 258.02M |
| Savara, Inc. | 1.119B |
| Vericel Corp. | 2.352B |
Market Cap Related Metrics
| PEG Ratio | -0.041 |
| Price to Book Value | 1.259 |
| Price | 8.97 |
| Earnings Yield | -64.82% |
| PEGY Ratio | -0.041 |